The European Medicines Agency has extended the mandate of its head, Amanda Adler Cooke. Health Canada announced measures to streamline regulatory inspections by recognizing other regulators’ assessments to reduce red tape for drug and device companies. Newly raised funds include Dewpoint Therapeutics’ Series D financing to advance a condensate modulator into clinical trials, while Nanonewron received a $2.5 million NIH grant for Alzheimer’s TNF-α inhibitor development. These updates signal continued investment and regulatory adaptations supporting biopharma innovation.